Henry Schein Inc. said Wednesday it will serve as the exclusive
distributor in the U.S. of a second point-of-care rapid test kit that
can detect antibodies associated with Covid-19 in as few as 15 minutes.
The health-care technology company said it is working with Becton
Dickinson & Co. and BioMedomics, a privately held clinical
diagnostics company, to make the test kits available to health-care
professionals.
The BioMedomics test analyzes blood, serum or plasma samples for the
presence of Immunoglobulin M and Immunoglobulin G antibodies associated
with the coronavirus. The test is completed in four steps. The results
can be read in 15 minutes.
The company said it is also a participant in the White House’s
Covid-19 Supply Chain Task Force, and has worked with the Strategic
National Stockpile to deliver personal protective equipment to Covid-19
testing sites, and is working with the Federal Emergency Management
Agency to source and deliver critical supplies quickly.
https://www.marketscreener.com/HENRY-SCHEIN-INC-9582/news/Henry-Schein-Harry-Schein-Exclusive-Distributor-of-Point-of-Care-Covid-19-Test-30288558/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.